Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Bronchiectasis".)
●(See "Society guideline links: Primary ciliary dyskinesia".)
●(See "Society guideline links: Noninvasive ventilation in adults".)
●(See "Society guideline links: Supplemental oxygen".)
●(See "Society guideline links: Pulmonary rehabilitation".)
●(See "Society guideline links: Subacute and chronic cough in adults".)
International
●Global Initiative for Asthma (GINA): Global strategy for asthma management and prevention, update (2023)
●Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, update (2023)
Canada
●Choosing Wisely Canada: Don't delay conversations about wishes and goals with patients who have serious or progressive chronic respiratory illness, such as COPD, IPF, PH, or CF. Unnecessary and potentially harmful treatments can be avoided by having discussions and documenting these conversations (2022)
●Choosing Wisely Canada: Don't initiate long-term maintenance inhalers in stable patients with suspected COPD if they have not had confirmation of post-bronchodilator airflow obstruction with spirometry (2022)
●Choosing Wisely Canada: Don't initiate long-term maintenance treatments (eg, bronchodilators, inhaled corticosteroids, leukotriene receptor antagonists, or other) in adult patients with suspected COPD/asthma without confirming a diagnosis with objective testing such as spirometry/methacholine challenge (2022)
●Canadian Thoracic Society (CTS): Clinical practice guideline on long-term non-invasive ventilation in patients with chronic obstructive pulmonary disease (COPD), update (2021)
●BC Guidelines: Chronic obstructive pulmonary disease (COPD) – Diagnosis and management (2017, updated 2020)
●CTS: Clinical practice guideline on pharmacotherapy in patients with COPD, update of evidence (2019)
●American College of Chest Physicians (CHEST) and CTS: Guideline for the prevention of acute exacerbations of COPD (2015)
United States
●US Preventive Services Task Force (USPSTF): Recommendation statement on chronic obstructive pulmonary disease – Screening (2022)
●American Thoracic Society (ATS): An official workshop report on challenges in the implementation of chronic obstructive pulmonary disease guidelines in low- and middle-income countries (2021)
●Department of Veterans Affairs (VA)/Department of Defense (DoD): Clinical practice guideline for the management of chronic obstructive pulmonary disease (2021)
●ATS: An official clinical practice guideline for pharmacologic management of chronic obstructive pulmonary disease (2020)
●ATS: Clinical practice guideline for long-term noninvasive ventilation in chronic stable hypercapnic chronic obstructive pulmonary disease (2020)
●ATS: An official workshop report on reducing chronic obstructive pulmonary disease hospital readmissions (2019)
●ATS and European Respiratory Society (ERS): An official statement on the occupational burden of nonmalignant respiratory diseases (2019)
●ERS/ATS: Guideline for management of COPD exacerbations (2017)
●ERS/ATS: Guideline for prevention of COPD exacerbations (2017)
●American College of Chest Physicians (CHEST) and Canadian Thoracic Society (CTS): Guideline for the prevention of acute exacerbations of COPD (2015)
●ATS/ERS: An official statement on limb muscle dysfunction in chronic obstructive pulmonary disease, update (2014)
●ERS/ATS: An official technical standard on field walking tests in chronic respiratory disease (2014)
●ATS: An official workshop report on the integrated care of the COPD patient (2012)
Europe
●European Respiratory Society (ERS): Clinical practice guideline on palliative care for people with chronic obstructive pulmonary disease or interstitial lung disease (2023)
●ERS: Statement on a core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations (2021)
●ERS: Guideline on withdrawal of inhaled corticosteroids in COPD (2020)
●American Thoracic Society (ATS) and ERS: An official statement on the occupational burden of nonmalignant respiratory diseases (2019)
●ERS: Guidelines on long-term home non-invasive ventilation for management of COPD (2019)
●ERS/ATS: Guideline for management of COPD exacerbations (2017)
●ERS/ATS: Guideline for prevention of COPD exacerbations (2017)
●ERS: Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit (2015)
●ATS/ERS: An official statement on limb muscle dysfunction in chronic obstructive pulmonary disease, update (2014)
●ERS: An official statement on physical activity in COPD (2014)
●ERS: Statement on nutritional assessment and therapy in COPD (2014)
●ERS/ATS: An official technical standard on field walking tests in chronic respiratory disease (2014)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Quality standard on chronic obstructive pulmonary disease in adults (2011, updated 2023)
●NICE: Medical technologies guidance on myCOPD for managing chronic obstructive pulmonary disease (2022)
●NICE: Interventional procedures guidance on endobronchial nerve ablation for chronic obstructive pulmonary disease (2021)
●NICE: Guideline on chronic obstructive pulmonary disease in over 16s – Diagnosis and management (2018, updated 2019)
●NICE: Guideline on chronic obstructive pulmonary disease (acute exacerbation) – Antimicrobial prescribing (2018)
Australia–New Zealand
●Lung Foundation Australia (LFA) and Thoracic Society of Australia and New Zealand (TSANZ): The COPD-X plan – Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease (2022)
●Choosing Wisely Australia: Do not initiate maintenance inhalers in minimally symptomatic COPD patients with a low risk of exacerbation (2021)
●Choosing Wisely Australia: Do not use long term systemic corticosteroids for management of chronic obstructive pulmonary disease (COPD) (2021)
Japan
●[In Japanese] Japanese Respiratory Society (JRS): Guidelines for diagnosis and treatment of COPD (chronic obstructive pulmonary disease), 6th edition (2022)
